“The antibiotic paradox” in allogeneic stem cell transplantation - Takeaways - MDSpire

“The antibiotic paradox” in allogeneic stem cell transplantation

  • By

  • Daniela Weber

  • Elisabeth Meedt

  • Sakhila Ghimire

  • Andreas Hiergeist

  • Michael A. G. Kern

  • Matthias Höpting

  • Erik Thiele Orberg

  • Haroon Shaikh

  • Andreas Beilhack

  • Daniel Wolff

  • Matthias Edinger

  • Wolfgang Herr

  • Andre Gessner

  • Hendrik Poeck

  • Ernst Holler

  • September 4, 2025

  • 0 min

Share

  • 1

    Blood stream infections (BSI) significantly increase mortality in allogeneic stem cell transplantation (ASCT) patients, affecting 13-30% of recipients.

  • 2

    Early and prolonged antibiotic use in ASCT leads to intestinal dysbiosis, increasing the risk of acute gastrointestinal Graft-versus-Host Disease (GvHD) and mortality.

  • 3

    The antibiotic paradox arises as antibiotics can both harm beneficial microbiota and suppress translocated bacteria that trigger GvHD, complicating treatment outcomes.

  • 4

    Dysbiosis erodes T-cell regulation, increasing GvHD susceptibility, while suppression of translocated bacteria may dampen T-cell activation and mitigate GvHD.

  • 5

    Implementing restrictive antibiotic protocols and improving diagnostic strategies may reduce antibiotic exposure and minimize dysbiosis risk in ASCT patients.

Original Source(s)

Related Content